Leerink Partners analyst David Risinger has reiterated their bullish stance on VRTX stock, giving a Buy rating yesterday.Invest with ...
Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...
The managers have typically avoided biotechnology, but added Regeneron Pharmaceuticals REGN in 2020 and then Vertex Pharmaceuticals ... in the context of these expenses, we think this share ...